Clinical Trials Logo
  1. Home
  2. Lewy Body Dementia
  3. NCT02640729

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

Lewy Body Dementia Clinical Trial

Official title:
A Phase 2, Double-blind, Randomized, Placebo-controlled Cross-over Study of Nelotanserin Versus Placebo in Lewy Body Dementia (LBD) Subjects Experiencing Visual Hallucinations (VH)

Clinical Trial Summary

This study seeks to evaluate safety and efficacy of Nelotanserin for the treatment of visual hallucinations in subjects with Lewy body dementia.

Clinical Trial Description

This is a double-blind, randomized, placebo-controlled, cross-over study in subjects with Lewy body dementia who experience frequent visual hallucinations.

Subjects who meet the randomization criteria enter the double-blind treatment period.

Each subject will be randomized 1:1 to one of the 2 treatment sequences: Nelotanserin in the first treatment period followed by placebo in the second treatment period, or placebo in the first treatment period followed by Nelotanserin in the second treatment period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02640729
Study type Interventional
Source Axovant Sciences Ltd.
Contact
Status Completed
Phase Phase 2
Start date December 2015
Completion date November 2017
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT05497817 - A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia N/A
Not yet recruiting NCT05499429 - Non-invasive Transcranial Focused Low-intensity Ultrasound Stimulation in Patients With Mild Lewy Body Dementia N/A
Recruiting NCT06337578 - Advances in Telephone-based Cognitive Screening Procedures
Terminated NCT02871427 - Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder Phase 2
Completed NCT03305809 - A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) Phase 2
Completed NCT00209456 - Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia Phase 3
Recruiting NCT06263673 - Anti-Diabetic Medications to Fight PD and LBD Phase 4
Recruiting NCT06389032 - PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia N/A
Terminated NCT05778695 - Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones N/A
Completed NCT00820937 - Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI) N/A
Active, not recruiting NCT05524181 - Telehealth-enabled Integrated Palliative Care for People With Dementia N/A
Completed NCT01339130 - Assessment of Social-emotional Functioning in Neurological Diseases N/A
Completed NCT04413851 - Feasibility of Passive Data Collection in Dementia Subjects With Agitation
Recruiting NCT03233646 - Retinal Imaging in Neurodegenerative Disease
Completed NCT02860338 - COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE N/A
Recruiting NCT05779839 - A Study of Caregiver Connections Via Technology in Dementia N/A
Completed NCT03550131 - Innovations in Dementia Empowerment and Action N/A
Recruiting NCT03019757 - Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Recruiting NCT05826457 - North American Prodromal Synucleinopathy Consortium Stage 2
Recruiting NCT06005935 - Environmental and Reproductive Health Risk for Lewy Body Dementia